RT Journal Article
SR Electronic
T1 Correction: Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003188corr1
DO 10.1136/jitc-2021-003188corr1
VO 9
IS 11
YR 2021
UL http://jitc.bmj.com/content/9/11/e003188corr1.abstract